Table 2.
Associations of patients’ characteristics with response to therapy with intramuscular MP in univariate logistic regression analyses and multivariate logistic regression analysis with imputations (n = 262).
| Variables | Odds ratio (95% CI) | P-value |
|---|---|---|
| Univariate logistic regression analyses | ||
| Age (years) | 1.00 (0.98, 1.03) | 0.463 |
| Female sex | 1.30 (0.73, 2.29) | 0.370 |
| BMI (≥30 kg/m2) | 0.95 (0.25, 3.58) | 0.945 |
| Comorbidities | ||
| Cardiovascular diseases | 1.01 (0.62, 1.65) | 0.971 |
| Diabetes mellitus | 0.59 (0.29, 1.18) | 0.136 |
| Thyroid disorders | 0.62 (0.29, 1.33) | 0.216 |
| Respiratory diseases | 1.49 (0.85, 2.63) | 0.166 |
| Neurological disorders | 2.12 (0.90, 4.97) | 0.085 |
| Osteoporosis | 1.25 (0.57, 2.77) | 0.579 |
| Carpal tunnel syndrome | 1.25 (0.57, 2.77) | 0.579 |
| Clinical presentation | ||
| Swollen joints | 1.22 (0.74, 2.00) | 0.431 |
| Limited joint function | 1.03 (0.51, 2.07) | 0.931 |
| Nodules | 0.70 (0.43, 1.16) | 0.168 |
| OA complaints in other joints | 1.15 (0.69, 1.91) | 0.587 |
| CRP (mg/l) (n = 142) | 1.08 (1.00, 1.17) | 0.047 |
| ESR (mm/h) (n = 103) | 1.03 (1.00, 1.06) | 0.092 |
| Radiologic abnormalities congruent to OA diagnosis (n = 184) | 0.69 (0.20, 2.39) | 0.564 |
| Number of classes of analgesic medication | 1.24 (0.94, 1.62) | 0.126 |
| Dose of injection (mg) | 1.07 (0.99, 1.15) | 0.085 |
| Multivariate logistic regression analysis with imputations | ||
| Diabetes mellitus | 0.59 (0.29, 1.20) | 0.146 |
| Number of classes of analgesic medication | 1.25 (0.95, 1.66) | 0.117 |
| CRP | 1.07 (0.99, 1.15) | 0.085 |